ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Revive Therapeutics Ltd (QB)

Revive Therapeutics Ltd (QB) (RVVTF)

0.00575
0.0002
( 3.60% )
更新日時: 01:14:10

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
0.00575
買値
0.0055
売値
0.006
出来高
171,723
0.0055 日の範囲 0.00588
0.005 52 週間の範囲 0.036
時価総額
前日終値
0.00555
始値
0.0058
最終取引時間
01:14:10
財務取引量
US$ 985
VWAP
0.005738
平均取引量 (3 か月)
498,557
発行済株式数
418,564,269
配当利回り
-
PER
-5.97
1 株当たり利益 (EPS)
-0.01
歳入
-
純利益
-5.62M

Revive Therapeutics Ltd (QB) について

セクター
Pharmaceutical Preparations
業界
Unit Inv Tr, Closed-end Mgmt
ウェブサイト
本社
Toronto, Ontario, Can
設立
2014
Revive Therapeutics Ltd (QB) is listed in the Pharmaceutical Preparations sector of the その他OTC with ticker RVVTF. The last closing price for Revive Therapeutics (QB) was US$0.01. Over the last year, Revive Therapeutics (QB) shares have traded in a share price range of US$ 0.005 to US$ 0.036.

Revive Therapeutics (QB) currently has 418,564,269 shares in issue. The market capitalisation of Revive Therapeutics (QB) is US$2.32 million. Revive Therapeutics (QB) has a price to earnings ratio (PE ratio) of -5.97.

RVVTF 最新ニュース

Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19

  Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19   TORONTO, Canada -- April 18, 2022 -- InvestorsHub NewsWire -- Revive...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

  Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   TORONTO, Canada -- April 12, 2022 -- InvestorsHub NewsWire -- Revive...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   Expected to seek DSMB approval to proceed with EUA application to the FDA in...

HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research

                              HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive...

Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation

 Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation  TORONTO, February 15, 2022 -- Revive...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19Ethics Committee approval to proceed with Phase 3 clinical trial in Turkey13 clinical sites selected to...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 701 subjects dosed to date Initiating enrollment activities in Turkey as part of its...

Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

 Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs IRB approval to initiate Phase 2 study for methamphetamine abuse disorders Advancing psilocybin oral thin film...

Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19

 Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19 Approximately 700 subjects participated in the enrollment periodExpected to begin subject enrollment...

Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection Delta Variant

 Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection Delta Variant TORONTO, November 16, 2021 -- InvestorsHub NewsWire -- Revive...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.00025-4.166666666670.0060.00670.0053896110.00609381CS
4-0.00025-4.166666666670.0060.007780.0054350380.00624987CS
12-0.00035-5.737704918030.00610.0120.0054985570.00695086CS
26-0.00625-52.08333333330.0120.01350.0053782510.00741118CS
52-0.01825-76.04166666670.0240.0360.0053553450.01327006CS
156-0.24425-97.70.250.390.0054322330.10733635CS
260-0.02975-83.80281690140.03550.720.00510596540.275585CS

RVVTF - Frequently Asked Questions (FAQ)

What is the current Revive Therapeutics (QB) share price?
The current share price of Revive Therapeutics (QB) is US$ 0.00575
How many Revive Therapeutics (QB) shares are in issue?
Revive Therapeutics (QB) has 418,564,269 shares in issue
What is the market cap of Revive Therapeutics (QB)?
The market capitalisation of Revive Therapeutics (QB) is USD 2.32M
What is the 1 year trading range for Revive Therapeutics (QB) share price?
Revive Therapeutics (QB) has traded in the range of US$ 0.005 to US$ 0.036 during the past year
What is the PE ratio of Revive Therapeutics (QB)?
The price to earnings ratio of Revive Therapeutics (QB) is -5.97
What is the reporting currency for Revive Therapeutics (QB)?
Revive Therapeutics (QB) reports financial results in CAD
What is the latest annual profit for Revive Therapeutics (QB)?
The latest annual profit of Revive Therapeutics (QB) is CAD -5.62M
What is the registered address of Revive Therapeutics (QB)?
The registered address for Revive Therapeutics (QB) is 82 RICHMOND STREET EAST, SUITE 105, TORONTO, ONTARIO, M5C 1P1
What is the Revive Therapeutics (QB) website address?
The website address for Revive Therapeutics (QB) is www.revivethera.com
Which industry sector does Revive Therapeutics (QB) operate in?
Revive Therapeutics (QB) operates in the UNIT INV TR, CLOSED-END MGMT sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
CRMBQCrumbs Bake Shop Inc (CE)
US$ 0.012
(11,900.00%)
500
MMATQMeta Materials Inc (CE)
US$ 0.0001
(9,900.00%)
336
ISUNQiSun Inc (CE)
US$ 0.0001
(9,900.00%)
5.22k
FCGDFirst Colombia Gold Corporation (PK)
US$ 0.0001
(9,900.00%)
1.6M
PPJEPPJ Healthcare Enterprises Inc (PK)
US$ 0.0001
(9,900.00%)
1.16M
RAASYCloopen Group Holding Limited (CE)
US$ 0.000001
(-100.00%)
1.27k
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0.000001
(-99.99%)
4.9k
CCFLUCCF Holdings LLC (CE)
US$ 0.0002
(-99.20%)
4.91k
NWTTNW Tech Capital Inc (PK)
US$ 0.000001
(-99.00%)
100k
FUVVArcimoto Inc (CE)
US$ 0.000001
(-99.00%)
522
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.0039
(2.63%)
551.86M
HMBLHUMBL Inc (PK)
US$ 0.00095
(5.56%)
223.83M
RDARRaadr Inc (PK)
US$ 0.00115
(-8.00%)
146.07M
IJJPIJJ Corporation (PK)
US$ 0.0004
(14.29%)
77.21M
AURIAuri Inc New (PK)
US$ 0.0002
(-20.00%)
77.09M

RVVTF Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock